Ok, for a day or so I will not harp on the negatives associated with its recent manufacturing woes or battles in the boardroom.
Today, I'll provide a small acknowledgement of success with the word of FDA approval for Lumizyme (alglucosidase alpha) for the treatment of Pompe disease.
Posted by Bruce Lehr May 26th 2010.


Comments